This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Synchrony Shines in Q3: Expense Management Drives Earnings Beat
by Zacks Equity Research
SYF expects net interest income to remain flat sequentially in the fourth quarter of 2024.
Allstate Acquires Kingfisher, Enhances Mobile Industry Offerings
by Zacks Equity Research
ALL's acquisition of Kingfisher bodes well. The acquisition aids in the enhancement of the company's Protection Plans offerings for smart devices.
Synchrony Streamlines Pet Care Payments With CareCredit Integration
by Zacks Equity Research
SYF's recent launch of an innovative integration between CareCredit and Pets Best insurance is aimed at simplifying the pet care payment process for pet parents.
Here's Why You Should Add Virtu Financial Stock to Your Portfolio
by Zacks Equity Research
Increasing market volatility and a solid Execution Services segment bode well for VIRT's growth in the future.
MarketAxess Reports Record Credit Trading Volumes for Q3
by Zacks Equity Research
MKTX reports strong growth in U.S. high-grade, emerging markets and eurobonds ADV in the third quarter.
Synchrony Partners With PSIvet, Expands CareCredit Offering
by Zacks Equity Research
SYF's partnership with PSIvet would expand payment options for pet owners and its CareCredit network.
American Express, Boost to Streamline Virtual Card Payment Processing
by Zacks Equity Research
AXP's partnership with Boost is expected to speed up the payment process by automating virtual card payment processing for eligible merchants.
Should You Retain Allstate Stock in Your Portfolio Now?
by Zacks Equity Research
ALL is set to benefit from improving premiums, enhanced distribution strategies and cost control efforts.
Synchrony and DICK'S Sporting Goods Extend Partnership to Boost Growth
by Zacks Equity Research
SYF renews its long-term partnership with DICK'S Sporting Goods, enhancing the ScoreRewards Credit Card program and driving growth in the retail finance sector.
CNO Financial's Washington National Enhances Insurance Product
by Zacks Equity Research
CNO enhances its Hospital Indemnity Insurance product in a bid to enhance offerings and improve retention.
Can Rithm Capital's 8.5% Yield Continue to Dance to the Dividend Tune?
by Zacks Equity Research
The positive impacts from RITM's asset management business acquisition will likely benefit its cash flows and support dividend payouts.
CNO Financial Up 19.6% in 3 Months: Will You Regret Not Buying in?
by Zacks Equity Research
CNO invests significantly in technology to improve agent productivity and sales.
MarketAxess Expands Partnership With BlackRock, Enhances Offerings
by Zacks Equity Research
MKTX expands its partnership with BlackRock to improve the trading experience for clients.
Virtu's Triton Valor EMS Connects Directly to Tokyo's CONNEQTOR
by Zacks Equity Research
This integration will help VIRT strengthen its presence in the Japanese market, potentially attracting new clients and expanding its global reach.
Hartford Financial Stock Jumps 42.5% YTD: Buy More or Buckle Up?
by Zacks Equity Research
HIG's balance sheet strength enables it to make shareholder value-boosting efforts.
Down -6.38% in 4 Weeks, Here's Why You Should You Buy the Dip in WisdomTree, Inc. (WT)
by Zacks Equity Research
WisdomTree, Inc. (WT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
RenaissanceRe Stock Near 52-Week High: Time to Lock in Gains?
by Zacks Equity Research
RNR's strong cash position supports its growth initiatives and shareholder returns.
Regional Management Stock Rises 16% in a Month: Should You Buy?
by Zacks Equity Research
RM continues to invest in its strategic and growth initiatives while keeping a tight grip on general and administrative expenses.
Here is Why Growth Investors Should Buy WisdomTree, Inc. (WT) Now
by Zacks Equity Research
WisdomTree, Inc. (WT) could produce exceptional returns because of its solid growth attributes.
AmEx (AXP) Down 2.7% on Spending Jitters: Wallets on Edge?
by Zacks Equity Research
Bank of America Securities analysts downgrade American Express (AXP) to Neutral from Buy.
Encore Capital (ECPG) Shares Rise 11.4% Since Q2 Earnings Beat
by Zacks Equity Research
Encore Capital (ECPG) expects interest expenses at $250 million for 2024 due to bond refinancing.
3 Reasons Why Growth Investors Shouldn't Overlook WisdomTree, Inc. (WT)
by Zacks Equity Research
WisdomTree, Inc. (WT) could produce exceptional returns because of its solid growth attributes.
Regional Management (RM) Declines 2.5% Despite Q2 Earnings Beat
by Zacks Equity Research
Regional Management (RM) foresees about 60-70 basis points year-over-year growth in total revenue yield for 2024.
Equitable Holdings (EQH) Declines 11% Despite Q2 Earnings Beat
by Zacks Equity Research
Equitable Holdings' (EQH) total AUM reaches $892.5 billion in the second quarter.
Here's Why You Should Add Globe Life (GL) to Your Portfolio
by Zacks Equity Research
Globe Life (GL) stands to gain from solid performance in its Life Insurance and Health Insurance segments, strong liquidity position and favorable estimates.